Ernst Young

F. B. Leit2 and E. I. Ewoldsen, Desalination 24, 321 (1978) E. B. Leit2, personal communication, U.S. Bureau of Reclamation, Denver, Colo., 1996. Ernst Young LLP, 1994 HationalWater andWastewater Rate Survey,Yd 2ASm. on,T3>. C., 1994. 

Muller A, Powlett Smith W, Mendoza-Vega O, MacCabe B et al. (2000) Evolution - Ernst Young s Seventh Annual European Life Sciences Report 2000, Ernst Young International, London... 

Source Based on year 2000 data reported by Ernst Young LLP, extracted from annual report of the listed companies. 

Source Data from Ernst Young LLP for the last four years except where indicated. Data from Sobering AG annual report 1999 and expressed in Euro-dollars. 

Ernst Young LLP, Convergence the biotechnology industry report, 2000, NY. 

Viability as measured by Ernst Young Survival Index, derived from the skew analysis. The estimates are expressed as the number of years of cash that companies have on hand based on current spending levels and on fiscal year-end numbers. 

Ernst, Young. Resilience The Americas BioTech Report, 2003. 

Ernst Young (2003) Transfer Pricing 2003 Global Survey. Ernst Young... 

Lee K, Burrill S, Biotech 97 Alignment (Ernst Young 11th Industry Annual Report), 1997. 

Biotech 93 Accelerating Commercialization. Industry annual report. Ernst Young, 1992... 

Faiella, C. (2002), Pharmaceutical Industry Report The Next Pharmaceutical Agenda, Ernst Young (www.ey.com). 

Ernst Young LLP, 1994 National Water and Wastewater R te Survej,SfJ C., 1994. 

Beyond Borders. Global Biotechnology Report 2005. Ernst Young, Palo Alto, CA, June 2005. 

Resurgence. The Americas Perspective. Global Biotechnology Report 2004. Ernst Young. Palo Alto, CA, June 2004. Resilience. Americas Biotechnology Report 2003. Ernst Young. Palo Alto, CA, July 2003. 

The Economic Contributions of the Biotechnology Industry to the US. Economy Ernst Young May 2000. 

Issue The Adaptive Enterprise Energy, Utilities Chemicals. Cap Gemini Ernst Young Center for Business Innovation, Paris, 2002. 

Cap Gemini Ernst Young Center for Business Innovation, Measures That Matter study. Survey of 300 sell-side analysts, 275 buy-side analysts, as well as interviews with portfolio managers. Summaries of these studies are available at http //www.cbi.cgey.com/. 

In 2002, Cap Gemini Ernst Young developed VCI models for the energy, utilities, and chemicals industries. About 70 of the largest United States-based companies are included in the data set after filtering for a minimum market capitalization in each industry, and for availability of data. The models ended up explaining at least 70 percent and up to 90 percent of the variability in market value in an industry. 

M. Kieman, Panel discussion on Sustainability Social and Environmental Factors in Financial Reporting, held at Cap Gemini Ernst Young Measuring the Future Conference, Cambridge, MA, October 1-3, 2000. Available at http //www.cbi.cgey.com/events/ pubconf/2000-10-4/ session/breakout/index.html sustainability. 

Figure 2.5 R D expenditures, ethicalpharmaceuticals, research-based pharmaceuticalcompanies, 1980-2000 (from PhRMA Annual Survey 1997 2000 expenditure from Ernst Young, 2001)...

McCaughan, M., A new era in drug safety regulation, Progressions, (Ernst Young), 24, 2007. 

External verification the CER contains a verification statement by Ernst Young that covers the whole of the report. The methodology included visits both to the Environmental and Safety Unit involved in collecting data and preparing the report, and to three production sites. 

Burrill, S., and Lee, K., Biotech 91, Changing Environment An Industry Annual Report (San Francisco, CA Ernst Young, 1990). 

Awareness of the biotechnology sector of these potential misuses of their work has increased since the anthrax attacks in the US in the fall of 2001. As the 2002 Ernst Young report notes ... 

Ernst Young s 13th Biotechnology Industry Ann Report (1999) Bridging the Gap. 36... 

---